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Abstract 
Background: The Tousled like kinase 1B (TLK1B) is critical for DNA repair and survival of cells. Upon DNA damage, 
Chk1 phosphorylates TLK1B at S457 leading to its transient inhibition. Once TLK1B regains its kinase activity it phos-
phorylates Rad9 at S328. In this work we investigated the significance of this mechanism by overexpressing mutant 
TLK1B in which the inhibitory phosphorylation site was eliminated.
Results and discussion: These cells expressing TLK1B resistant to DNA damage showed constitutive phosphoryla-
tion of Rad9 S328 that occurred even in the presence of hydroxyurea (HU), and this resulted in a delayed checkpoint 
recovery. One possible explanation was that premature phosphorylation of Rad9 caused its dissociation from 9-1-1 at 
stalled replication forks, resulting in their collapse and prolonged activation of the S-phase checkpoint. We found that 
phosphorylation of Rad9 at S328 results in its dissociation from chromatin and redistribution to the cytoplasm. This 
results in double stranded breaks formation with concomitant activation of ATM and phosphorylation of H2AX. Fur-
thermore, a Rad9 (S328D) phosphomimic mutant was exclusively localized to the cytoplasm and not the chromatin. 
Another Rad9 phosphomimic mutant (T355D), which is also a site phosphorylated by TLK1, localized normally. In cells 
expressing the mutant TLK1B treated with HU, Rad9 association with Hus1 and WRN was greatly reduced, suggesting 
again that its phosphorylation causes its premature release from stalled forks.
Conclusions: We propose that normally, the inactivation of TLK1B following replication arrest and genotoxic stress 
functions to allow the retention of 9-1-1 at the sites of damage or stalled forks. Following reactivation of TLK1B, whose 
synthesis is concomitantly induced by genotoxins, Rad9 is hyperphosphorylated at S328, resulting in its dissociation 
and inactivation of the checkpoint that occurs once repair is complete.
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Background
The Tousled (Tsl) gene was first identified in the plant 
Arabidopsis thaliana. Recessive Tsl mutants show defects 
in leaf and flower development [1]. This was proposed to 
be linked to a replicative defect during organogenesis, but 
it may also result from failure to protect the genome from 
DNA damage [2–4], resulting in developmental aberra-
tions [5, 6]. Animal homologs of Tousled, known as Tou-
sled like kinases (TLKs), are found from Caenorhabditis 
elegans to mammals. They are generally considered as 
genes of metazoans and are not found in yeast, although 
they are present in unicellular trypanosomes [7]. In 
mammals their activity is cell cycle regulated with max-
imal activity found in the S-phase. After many years of 
study, only a few direct “interacting” substrates of TLKs 
have been identified, namely the histone chaperone Asf1 
[8], histone H3 [9], Rad9 [10], and Aurora B kinase [5]. As 
evident from their substrates, TLKs play a major role in 
chromatin assembly [10, 11], transcription [4, 12], DNA 
repair [3, 10, 13], and condensation of chromosomes at 
mitosis [5, 6]. In humans two structurally similar TLK 
genes (TLK1 and TLK2) with several splice variants have 
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been identified. A splice variant of TLK1, TLK1B that 
lacks the first 237 amino acids was identified in our lab. 
TLK1 and TLK1B interact with similar substrates, are 
believed to have similar enzymatic functions and are 
often referred to as TLK1/1B. Our previous studies have 
shown that translation of TLK1B is induced by DNA 
damage through the activation of the mTOR-eIF4E path-
way. We have shown that elevated expression of TLK1B 
promotes cell survival after irradiation (IR) or doxoru-
bicin [13] and UV [3] by facilitating DNA repair and pro-
moting chromatin assembly after repair. Expression of a 
dominant-negative mutant of TLK1B renders mamma-
lian cells sensitive to IR [6]. Thus, the human homolog, 
TLK1B, has invoked interest because of its established 
role in cell survival after DNA damage [3, 9, 13]. Iden-
tification of Rad9 as a substrate for TLK1/1B attributes 
a direct role of TLK1/1B in DNA repair [14]. Our pre-
vious work suggests that TLK1/1B’s chaperone activity, 
independent of its kinase activity, helps in the recruit-
ment of Rad9 at the break site. We had previously shown 
some evidence that TLK1/1B kinase activity is important 
for the dissociation of Rad9-Rad1-Hus1 (9-1-1) complex 
from a double stranded break (DSB) [14].
Rad9 plays a major role in DNA repair, cell cycle 
checkpoint and apoptosis. Aberrant Rad9 expression 
has been linked to breast, lung, thyroid, skin and pros-
tate tumorigenesis [15]. Rad9 is a part of 9-1-1 hetero-
trimeric complex which is required for activation of 
ATR. Rad9, Rad1 or Hus1 KO mice are embryonic lethal 
[16, 17]. Loss of Rad9 produces a defect in ATR sign-
aling and increases the sensitivity of the cells towards 
genotoxic stress [18]. In response to replication stress 
RPA directs the clamp loader RAD17–replication fac-
tor C (RFC) to load the 9-1-1 complex at the 5′ end of 
the double strand-single strand DNA junctions [19, 
20]. Chromatin-bound 9-1-1 complex acts as a scaf-
fold for the recruitment of various DNA repair pro-
teins and polymerases at the DNA damage break site. It 
ensures filling of gaps and efficient repair of DNA [21, 
22]. Recently it has been shown that 9-1-1 complex is 
required for the recruitment of WRN protein at stalled 
replication forks and this interaction is important for 
the fork recovery [23]. WRN belongs to the RecQ family 
of DNA helicases. Loss of WRN gives rise to a genetic 
disease known as Werner syndrome (WS). It is char-
acterized by pre-mature ageing and pre-disposition 
to cancer [24, 25]. Cells derived from the WS patients 
show a prolonged S-phase, a reduced life-span, and 
an increase in genomic instability [26, 27]. It has been 
shown that WRN stabilizes the stalled replication forks 
and the loss of WRN leads to the fork collapse and 
increase in DSBs that are repaired through recombi-
nation [28]. WRN interacts with the 9-1-1 complex to 
maintain genomic stability by preventing accumulation 
of DSBs at the damaged forks [23].
Activation of the DNA damage induced checkpoint 
mediates rapid and transient inhibition of TLK activity. 
This transient inhibition in response to DNA damage 
requires ATM and Chk1 function. Chk1 directly phos-
phorylates TLK1 at S695 which is equivalent to S457 of 
TLK1B [29]. Once TLK1/1B regains its kinase activity it 
phosphorylates Rad9 at S328 [10] and T355 [30]. Rad9 
S328 phosphorylation follows the pattern of TLK1/1B 
activity wherein it is inhibited immediately after DNA 
damage and gets phosphorylated when TLK1/1B regains 
its activity [14, 31]. The reason for this transient inac-
tivation of TLK1/1B still remains a question as there 
is a lack of direct evidence for the role of this inhibi-
tory phosphorylation with regards to its effect on Rad9 
and ATR mediated cell signaling. In order to answer 
this question we have made an S457A mutant (Mut) of 
TLK1B that lacks the inhibitory phosphorylation site. 
In this study we show that Mut TLK1B remains active 
in the presence of DNA damage, and cells overexpress-
ing it display an altered cell cycle checkpoint and delay 
in cell cycle progression upon recovery from hydroxyurea 
(HU). Mut TLK1B overexpressing cells show an increase 
in phosphorylation of Rad9 at S328. In response to HU 
mediated replication arrest, Mut TLK1B overexpressing 
cells show a massive reduction in the formation of Rad9 
foci and reduced association of Rad9 with the chroma-
tin. Mut TLK1B expressing cells show reduced associa-
tion of Rad9 with Hus1 and WRN suggesting an early 
dissociation of 9-1-1 complex. In response to HU, these 
cells show an increased accumulation of DSBs which are 
marked by an increase in association of p-ATM (S1981) 
and γ-H2AX with the chromatin. Cellular fractiona-
tion data of Mut TLK1B overexpressing cells showed an 
increase in the accumulation of total Rad9 and p-Rad9 
(S328) in the cytoplasm. Furthermore, studies with Rad9 
S328D phosphomimetic mutant suggest that the phos-
phorylation of Rad9 at S328 alone is sufficient to prevent 
Rad9 localization into the nucleus. Our results indicate 
that in response to replication arrest, transient inhibition 
of TLK1/1B is crucial to maintain localization of Rad9 
into the nucleus at damage sites.
Results
Mut TLK1B increases phosphorylation of Rad9 at S328 
both in presence and absence of DNA damage
We generated a S457A TLK1B mutant which lacks the 
Chk1 inhibitory phosphorylation site and cloned it into 
the pIRES2-EGFP vector. We then generated HEK293 
stable cell lines overexpressing mutant (Mut) and wild-
type (Wt) TLK1B, after selection for high GFP positive 
cells (methods). Figure 1a confirms the overexpression of 
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Wt and Mut TLK1B in HEK293 cells. Further, after treat-
ment with doxorubicin (doxo, topoisomerase II inhibitor 
that causes accumulation of DSBs upon which Rad9 is 
loaded) Wt TLK1B shows an increase in phosphorylation 
at S457 whereas the phospho-specific antibody doesn’t 
recognize the overexpressed Mut TLK1B (Fig.  1b). The 
mutant and empty vector (EV) show a slight band of 
p-TLK1B S457 attributable to the endogenous TLK1B 
that is translationally induced after doxo treatment [9, 
32]. In comparison with the Wt and EV, the basal level 
of Rad9 phosphorylation is elevated in the Mut TLK1B 
expressing cells (Fig.  1c). In the Mut TLK1B express-
ing cells the phosphorylation of Rad9 is not suppressed 
after DNA damage, either with doxo (Fig.  1d) or HU 
(Fig.  1e), which suggests that the Mut kinase is active 
even in the presence of DNA damage. In Wt cells, Rad9 
phosphorylation at S328 is initially very low and progres-
sively increases by 6–8 h of recovery from HU (Fig. 1e). 
In Mut TLK1B cells, the phosphorylation of Rad9 is 
elevated after release from HU but decreases after 8 h of 
recovery, possibly due to the activation of a phosphatase. 
HU depletes the deoxyribonucleotide pools that results 
in replication fork stalling, leading to recruitment of 
Rad9.
Cells expressing Mut TLK1B show defects in formation 
of Rad9 foci
When cells are exposed to replication stress Rad9 pro-
tein is redistributed to form discrete nuclear foci at the 
sites of DNA damage [33]. The recruitment of the 9-1-1 
complex at the sites of DNA damage can be visualized by 
looking at the formation of Rad9 foci [34]. We showed 
Fig. 1 a Overexpression of Wt TLK1B and Mut TLK1B in stably transfected HEK293 cells. b TLK1B Wt and Mut cells or empty vector controls (EV) 
were treated for 2 h with doxo to promote the Chk1-dpendent phosphorylation of TLK1B (S457). TLK1B S457 phospho specific antibody recognizes 
only the overexpressed Wt TLK1B and not the Mut TLK1B. Note that the p-TLK1B band seen in the Mut lane corresponds to the endogenous TLK1B 
and not the transfected TLK1B Mut. c The basal phosphorylation of Rad9 (S328) is enhanced in cells expressing Mut TLK1B with respect to EV or cells 
expressing Wt TLK1B. d The phosphorylation of Rad9 (S328) persists in damage resistant Mut TLK1B expressing cells treated with doxo. e Pattern of 
Rad9 (S328) phosphorylation after recovery from HU in the cells expressing Mut TLK1B or Wt TLK1B. Note that TLK1B overexpression is unaffected by 
HU treatment in these cells
Page 4 of 16Awate and De Benedetti  BMC Molecular Biol  (2016) 17:3 
that in response to DNA damage Rad9 S328 phospho-
rylation persists in the cells overexpressing Mut TLK1B. 
We wanted to examine whether TLK1B mutant cells 
show any defects in formation of Rad9 foci. In order to 
look at the Rad9 foci associated with chromatin, solu-
ble proteins were removed before fixation (as described 
in “Methods” section). In comparison with the Wt, cells 
expressing Mut TLK1B showed a drastic reduction in the 
formation of Rad9 foci. The Wt cells had much brighter 
and greater number of Rad9 foci (Fig. 2a, b) in compari-
son with the Mut TLK1B expressing cells. When the sol-
uble proteins were not removed before fixation we saw an 
increased accumulation of Rad9 in the cytoplasm in the 
Mut TLK1B expressing cells (Additional file 1: Figure S1).
Cells expressing Mut TLK1B show reduction in association 
of Rad9 with the chromatin
It has been shown that replication stress stimulates the 
association of Rad9 with the chromatin [35]. We next 
wanted to see if this phosphorylation may result in early 
dissociation of Rad9 from the chromatin in these cells. 
To study association and dissociation kinetics of Rad9 in 
the cells expressing Wt and Mut TLK1B we performed 
chromatin fractionation assay after treating cells with 
HU and allowing them to recover. In the Wt TLK1B 
expressing cells Rad9 was largely associated with the 
chromatin fraction at recovery time t = 0 (Fig. 3a). Rad9 
was found in the chromatin bound fraction until 4 h of 
recovery period. However at around 6 to 8 h of recovery 
time the Rad9 levels decreased in the chromatin bound 
fraction. A very different pattern was seen in the Mut 
TLK1B expressing cells (Fig. 3a). These cells had very low 
levels of Rad9 bound to the chromatin fraction until 4 h 
of recovery period (significantly lower than Wt express-
ing cells). However after 6  h of recovery time the Rad9 
levels increased in the chromatin bound fraction. We 
believe that this is due the accumulation of DNA damage 
(including DSBs) at this time, and that this may trigger 
a mechanism for the re-import of Rad9 into the nucleus 
that is independent on S328 phosphorylation by TLK1B.
Fig. 2 a Rad9 foci in the TLK1B Wt and Mut overexpressing cells were examined after removing the soluble proteins and fixing chromatin bound 
proteins (methods). b Quantitative analysis of the Rad9 foci per cell averaged over 100 cells per data point. All the experiments were performed 
independently at least three times. Values are mean ± SE
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Cells expressing Mut TLK1B show an increased 
accumulation of Rad9 and p‑Rad9 S328 in the cytoplasmic 
fraction
Through fractionation we obtained cytoplasmic, soluble 
nuclear and chromatin bound proteins. Correct distribu-
tion was confirmed by immunoblots using tubulin and 
ORC2 antibodies (Fig.  4a). We expected that the phos-
phorylation of Rad9 at S328 would cause the release of 
Rad9 from chromatin fraction into the soluble fraction. 
When we analyzed the cytoplasmic fraction we saw a 
reciprocal distribution where the decrease of Rad9 from 
the chromatin fraction (Fig.  3a) corresponded with its 
increase in the cytoplasmic fraction (Fig.  3b) and vice 
versa. It should be noted that Rad9 in the cytoplasm 
appears as a single band, but gets phosphorylated on 
multiple residues once it gets loaded onto the chroma-
tin, resulting in the appearance of multiple bands [36]. 
In the Wt TLK1B expressing cells until 2–4  h of recov-
ery time, low levels of Rad9 were present in the cytoplas-
mic fraction as most of it was bound to the chromatin. 
However, around 6 h of recovery in these cells Rad9 lev-
els decreased in the chromatin bound fraction and cor-
respondingly increased in the cytoplasmic fraction. In 
the Mut TLK1B expressing cells, most of Rad9 was found 
in the cytoplasm until 4 h of recovery; however, around 
6–8  h of recovery time Rad9 levels in the cytoplasm 
gradually decreased and correspondingly increased in 
the chromatin bound fraction. During replication stress 
Mut TLK1B expressing cells had increased levels of 
p-Rad9 S328 (Fig.  3c) in the cytoplasm. The pattern of 
Rad9 S328 phosphorylation in the cytoplasmic fraction 
exactly matched the pattern of total Rad9 (Fig. 3b) sug-
gesting that the phosphorylation of Rad9 at S328 may 
be responsible for its accumulation in the cytoplasm. 
Previously using an adeno-HO-mediated cleavage sys-
tem in MM3MG cells, we had shown that overexpres-
sion of kinase dead TLK delays the release of Rad9 and 
Rad17 upon repair of the DSB [14]. In our previous 
study we identified specific TLK inhibitors that prevent 
the TLK-mediated phosphorylation of Rad9 at S328 and 
cause defects in checkpoint recovery [31]. Mut TLK1B 
overexpressing cells, showing an increased TLK1B activ-
ity, showed an early dissociation of the Rad9 from the 
chromatin. We next wanted to examine if inhibition of 
TLKs with specific inhibitor Thioridazine hydrochloride 
(THD) leads to an increase in association of Rad9 with 
the chromatin. As expected, we saw an increased associa-
tion of Rad9 onto the chromatin in the presence of THD 
(Fig. 3d). Also Rad9 remained bound onto the chromatin 
for longer time in the presence of the THD (Fig. 3d).
Phosphomimetic Rad9 S328D mutant is sufficient 
to accumulate Rad9 in the cytoplasm
We next wanted to examine if phosphorylation of Rad9 
at S328 is sufficient to alter the nuclear localization of 
Rad9. In order to do so we generated a phosphomimetic 
flag-tagged Rad9 S328D mutant (as described in “Meth-
ods” section). Fractionation was performed on the cells 
overexpressing the flag-tagged Rad9 S328D mutant and 
flag-tagged Wt Rad9. These cells were incubated with or 
without HU. After fractionating the cytoplasmic, soluble 
nuclear and chromatin bound proteins the distribution of 
Rad9 was examined by immunoblotting with either anti-
flag antibody to specifically detect overexpressed flag-
tagged Wt or Mut Rad9 (Fig. 4b) or anti-Rad9 antibody 
to detect both the endogenous and overexpressed Rad9 
(Fig. 4c). Immunoblotting with anti-flag antibody showed 
that the overexpressed Rad9 S328D mutant was local-
ized exclusively in the cytoplasm while the overexpressed 
Wt Rad9 was present in all the three fractions (Fig. 4b). 
These results confirm that the phosphorylation of Rad9 
at S328 is sufficient to accumulate Rad9 in the cytoplasm. 
As previously mentioned multiple Rad9 bands appear in 
the chromatin fraction due to phosphorylation of Rad9 
at multiple sites. Cellular fractionation results were con-
firmed by immunolocalization (as described in “Meth-
ods” section), which showed that the flag-tagged Rad9 
(S328D) localized to the cytoplasm whereas the Wt Rad9 
was nuclear (Fig. 4d).
Phosphomimic Rad9‑T355D does not affect its nuclear/
cytoplasmic localization
Scott Davey`s group has recently found Rad9 T355 as 
another phosphorylation site of TLK1 [30]. Interestingly 
T355 lies next to nuclear localization sequence (NLS), 
which starts at the residue 356 and ends at 364. Bioinfor-
matics analysis with cNLS mapper predicted that Rad9 is 
localized exclusively in the nucleus, and T355D mutation 
(See figure on previous page.) 
Fig. 3 a Distribution of Rad9 in the chromatin-bound fraction in Wt and Mut TLK1B expressing cells in response to treatment and recovery from 
HU. Values are mean ± standard error for n = 3. b Distribution of Rad9 in the cytoplasmic fraction in Wt and Mut TLK1B expressing cells. Note that 
the Rad9 in the cytoplasm appears as a single band, but in the chromatin fraction appears as multiple bands. Rad9 gets multiply phosphorylated 
only once it gets loaded onto the chromatin. Values are mean ± SE for n = 3. c Distribution of p-Rad9 (S328) in the cytoplasmic fraction in Wt vs 
Mut TLK1B expressing cells. Note that p-Rad9 (S328) is predominantly cytoplasmic and is elevated in Mut TLK1B expressing cells during replication 
stress. Values are mean ± standard error for n = 3. d Distribution of Rad9 in the chromatin-bound fraction in HEK293 cells in response to treatment 
and recovery from HU in the presence or absence of TLK inhibitor (THD)
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in Rad9 would cause a partial cytoplasmic accumulation. 
Our cellular fractionation data of Mut TLK1B overex-
pressing cells showed an increase in the accumulation of 
total p-Rad9 (T355) in the cytoplasm but it was unclear if 
this simply reflected the total Rad9 level, i.e., phosphoryl-
ated also at S328 (Additional file 2: Figure S2A). We next 
Fig. 4 a Verification of fractionation procedure by probing for ORC2 which is chromatin-bound and tubulin which is cytoplasmic. b α-Flag Ab 
detects only the overexpressed flag tagged Wt and Rad9 (S328D) mutant. c α-Rad9 Ab detects both the endogenous and the overexpressed Wt 
and Rad9 (S328D) mutant. d Immunolocalization shows that the Rad9 (S328D) mutant localizes primarily in the cytoplasm in contrast to the WT 
protein which is mostly nuclear
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wanted to examine if phosphorylation of Rad9 at T355 
can alter the nuclear localization of Rad9. In order to do 
so we generated a phosphomimetic flag-tagged T355D 
mutant. The Rad9 T355D mutant was also found in the 
chromatin and nucleoplasmic fractions, although the 
chromatin to cytoplasmic ratio for the T355D mutant 
was not identical to the wt Rad9 (Additional file 2: Figure 
S2B).
Mut TLK1B expressing cells show reduced association 
of Rad9 with Hus1 and WRN
Stable 9-1-1 complex is required for the recruitment of 
WRN at the stalled replication forks. Replication stress 
stimulates the interaction of Rad9 with Hus1 [37] and 
WRN [23]. Inactivation resistant Mut TLK1B accumu-
lates Rad9 in the cytoplasm which would affect recruit-
ment of WRN at stalled replication forks. In order to 
examine the stability of the 9-1-1 complex and WRN 
recruitment we examined the interaction of Rad9 with 
Hus1 and WRN in the Wt and Mut TLK1B express-
ing cells. Cell lysates were immunoprecipitated with an 
anti-Rad9 antibody and analyzed for the association with 
Hus1 and WRN. In the untreated Wt TLK1B express-
ing cells Rad9 was associated with Hus1 (Fig.  5b) and 
WRN (Fig.  5c) and this was stimulated upon treatment 
with HU. However, Mut TLK1B expressing cells showed 
reduced association of Rad9 with Hus1 (Fig.  5b) and 
WRN (Fig. 5c), suggesting that the Mut TLK1B reduces 
the stability of 9-1-1 and its interaction with WRN.
We next wanted to examine if the overexpressed Rad9 
S328D mutant (flag tagged) can interact with WRN and 
Hus1 since this association should occur largely on chro-
matin. Immunoprecipitation of the overexpressed Rad9 
S328D mutant using flag antibody showed that the inter-
action of mutant Rad9 with WRN and Hus1 was greatly 
impaired, while the overexpressed wt Rad9 was able to 
bind normally (Fig. 5e, f ). In this case, the addition of HU 
did not increase the association of wt Rad9 with WRN 
and Hus1 probably due to the overexpression of the 
protein.
Mut TLK1B expressing cells show increased amount of DNA 
damage
It has been shown that the interaction between WRN 
and the 9-1-1 complex prevent DSB formation at the 
stalled replication forks [38]. The fraction of WRN bound 
to chromatin (Fig.  6b) after treatment and release from 
HU is significantly reduced in the Mut TLK1B express-
ing cells, particularly at recovery period of 0 h (p < 0.05), 
when maximum number of fork are stalled. We next 
wanted to examine if the Mut TLK1B expressing cells 
show an increase in DSBs. In response to DSBs, ATM is 
autophosphorylated at S1981. This autophosphorylation 
stabilizes ATM at the DSBs and is a marker of ATM acti-
vation. Prolonged treatment with HU generates DSBs. In 
the chromatin bound fraction of Wt TLK1B expressing 
cells at the recovery period of 0 h we saw increased lev-
els of p-ATM S1981 (Fig. 6c). However after 4 h of recov-
ery there was a decrease in p-ATM S1981 suggesting 
that most of the DSBs have been repaired. In compari-
son, Mut TLK1B expressing cells showed increased levels 
of p-ATM (Fig.  6c) until 8  h of recovery time (statisti-
cally significant). Activated ATM phosphorylates H2AX 
at S139, which is known as γ-H2AX. In the Wt TLK1B 
expressing cells γ-H2AX was present only until 4  h of 
recovery period; however, the Mut TLK1B expressing 
cells showed increased levels of γ-H2AX till 8 h of recov-
ery time (Fig. 6d). These results suggest that in response 
Fig. 5 a Immunoprecipitation of Rad9 in Wt and Mut TLK1B express-
ing cells. b HU treatment results in increased formation of 9-1-1 
complex as indicated by the increased association of Rad9 with 
Hus1. This interaction is greatly diminished in Mut TLK1B expressing 
cells. c Co-immunoprecipitation of WRN with Rad9 is also is greatly 
diminished in Mut TLK1B expressing cells. d Immunoprecipitation 
of overexpressed flag tagged Rad9 in Wt and (S328D) Mut Rad9 
expressing cells. e Co-immunoprecipitation of Hus1 with overex-
pressed flag-Rad9 is diminished in Rad9 S328D Mut expressing cells. 
f Co-immunoprecipitation of WRN with overexpressed flag-Rad9 is 
diminished in Rad9 S328D Mut expressing cells
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to replication stress Mut TLK1B expressing cells have an 
increase in DSBs that persist beyond 8 h of recovery.
Activation of ATM is essential for formation of 
γ-H2AX [39]. Studies from several groups have shown 
that ATM activation and H2AX phosphorylation can 
occur even in the absence of DSBs. [40–42]. Since we 
observed both activation and persistence of ATM and 
γ-H2AX in Mut TLK1B expressing cells, we probed for 
presence of DSBs in these cells by comet assays. We 
observed comets with large tail length and tail moment 
in the Mut TLK1B expressing cells (Fig.  7) after treat-
ment and recovery from HU, whereas comets were not 
present at these times in control cells.
HU treatment of Mut TLK1B expressing cells show a delay 
in cell cycle progression and recovery
We wanted to study the effect of this damage resistant 
kinase on cell cycle progression and recovery from HU 
induced replication arrest. Treatment with HU causes 
the cells to accumulate at the G1/S boundary. Washing 
away the HU allows completion of S-phase and then 
synchronous entry into G2/M-phase, and then re-entry 
into the G1-phase of the next cycle. Cells overexpress-
ing Wt TLK1B (Fig. 8a) when released from HU complete 
S-phase at around 8  h of recovery, synchronously enter 
into G2/M-phase at around 10 h and then re-enter into 
the G1 after 12  h. At around 14  h all the Wt cells have 
recovered. In contrast, Mut TLK1B overexpressing cells 
(Fig. 8b) remain arrested in the S-phase for 10 h. By 12 h 
only 7  % of Mut TLK1B expressing cells re-enter back 
into the G1-phase, in comparison to 35 % of cells express-
ing Wt TLK1B. By 14 h Mut TLK1B expressing cells still 
remain in the S- and G2-phase in comparison with the 
cells expressing Wt TLK1B which mostly re-enter into 
G-1 phase by that time. Thus, in response to replication 
stress cells expressing inactivation resistant Mut TLK1B 
arrest in the S- and G2-phase and show delay in re-entry 
into the cell cycle. We should stress that in the absence 
of HU the cell cycle profile is undistinguishable from Wt 
TLK1B or parental cells (not shown here). Comet assays 
also showed no presence of DSBs in the absence of HU 
treatment.
Fig. 6 a Distribution of WRN, p-ATM (S1981) and γH2AX in the chromatin-bound fraction in Wt and Mut. TLK1B expressing cells in response to treat-
ment and recovery from HU. b Less WRN is found in association with chromatin in cells expressing Mut TLK1B particularly at recovery time t = 0. 
Values are mean ± standard error for n = 3. c p-ATM (S1981) associated with chromatin persists during recovery from HU in cells expressing Mut 
TLK1B. Values are mean ± SE for n = 3. d γH2AX persists during recovery from HU in cells expressing Mut TLK1B. Values are mean ± SE for n = 3
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Mut TLK1B expressing cells display an altered checkpoint 
control
ATR is the primary kinase that phosphorylates RPA2 
at T21 after HU treatment [43, 44]. Phosphorylation of 
RPA by ATR stimulates DNA synthesis and prevents 
ssDNA accumulation during replication stress [45]. Since 
less Rad9 was associated with the chromatin in the Mut 
TLK1B expressing cells, we expected to see a reduced 
phosphorylation of the ATR substrates in these cells. 
As expected, we observed a reduced phosphorylation of 
RPA2 T21 in the Mut TLK1B expressing cells (Fig.  9a). 
However, we didn’t observe a reduction in Chk1 phos-
phorylation (Fig. 9a). In Mut TLK1B expressing cells we 
saw an increased accumulation of DSBs and ATM acti-
vation. Since we observed Chk1 phosphorylation in the 
Mut TLK1B expressing cells, we wanted to examine if 
this was mediated via ATM. It has been shown that ATM 
and ATR pathways exhibit a high degree of crosstalk [46–
49]. ATM has been shown to phosphorylate Chk1 in vitro 
and increase in DSB accumulation has been shown to 
induce ATM mediated phosphorylation of Chk1 [50, 51]. 
Treatment with a specific ATM inhibitor (KU-55933) 
showed a slight reduction in Chk1 phosphorylation in the 
Mut cell line (Fig. 9b), suggesting that the increased Chk1 
phosphorylation in these cells could be due to an increase 
in ATM activity, as shown in Fig. 6. Since we know that 
ATR is inhibited in these cells due to the lack of chroma-
tin bound Rad9, there is the possibility that part of the 
Chk1 phosphorylation is instead due to the activity of 
DNA-PKcs in Mut TLK1B expressing cells [52–54]—this 
needs to be investigated further.
Discussion
Tousled Like kinases (TLK) are serine/threonine kinases 
that play an important role in DNA repair. TLK overex-
pression is observed in multiple cancers and often cor-
responds to reduced sensitivity towards radiotherapy or 
chemotherapy due to the efficient repair in those tumors 
[32, 55]. Our lab identified TLK1B, which is a splice 
variant of TLK1 gene from a library of mRNAs that are 
translationally upregulated by overexpression of transla-
tion initiation factor 4E. TLK1B is known to protect cells 
Fig. 7 Comet assays was performed to measure the amount of unrepaired DNA damage in untreated cells or cells treated with 2 mM HU and 
recovery for indicated time points. a Representative images of the different time points. b Tail moments (tail DNA % × length of tail) as quantified 
for each cell using ImageJ OpenComet plugin. 50 comet images were measured for each treatment
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from genotoxic stress and is translationally upregulated 
in response to stress and DNA damage via mTOR-eIF4E 
pathway [13, 56]. At the same time, genotoxic stress 
leads to Chk1 mediated transient inactivation of TLK 
[11]. TLK1B promotes repair of damaged DNA in coop-
eration with Rad9 by facilitating the assembly of repair 
proteins to the sites of DNA damage. TLKs are the only 
kinases that phosphorylate Rad9 at S328. Rad9 is aber-
rantly expressed in prostate, breast, thyroid, skin, lung, 
and gastric cancers [57, 58]. It plays a major role in cell 
cycle checkpoint and DNA damage repair. It is essential 
for genomic stability as frequent chromosomal break-
age is observed in cells in which both the Rad9 alleles 
are inactivated [59, 60]. Rad9, a member of PCNA-like 
9-1-1 complex, contains 110 amino acid long C-terminal 
region that does not share homology with PCNA. This 
C-terminal region of Rad9 is extensively modified by 
phosphorylation. Some residues are constitutively phos-
phorylated while some are transiently phosphorylated 
in response to DNA damage and cell cycle position [36, 
61]. In response to DNA damage, once TLK1B regains its 
kinase activity it transiently phosphorylates Rad9 at S328. 
In this study we wanted to elucidate the significance of 
this phosphorylation.
It has been shown that the stable 9-1-1 complex is 
required for WRN localization at the stalled replica-
tion forks [23], and is necessary for the ATR-dependent 
phosphorylation of WRN following replication fork 
stalling [62]. The possible role of the TLK1B mediated 
phosphorylation of Rad9 on its interaction with WRN 
was not known. In this work we investigated the sig-
nificance of the inhibition of TLK1B activity following 
replication stress and its consequence for Rad9 phospho-
rylation in relation to the DNA damage response (DDR) 
and checkpoint recovery. In previous studies using a 
kinase dead TLK1B we have found that the release of 
Rad9 from a DSB induced with HO nuclease was delayed 
well beyond the time required to repair the break [14]. 
Conversely, in this work we report that constitutive 
phosphorylation of Rad9 by the mutant TLK1B after 
release from HU results in its dissociation from chro-
matin and translocation to the cytoplasm (Fig. 10). Con-
sistent with this model, the Rad9 (S328D) mutant was 
found exclusively in the cytoplasm and didn’t associate 
with the chromatin. We also studied the consequences 
of this effect of inactivation resistant TLK1B mutant on 
DDR and cell cycle checkpoint. We found that the cells 
delayed in cell cycle recovery following release from HU 
and remained in the S- and G2 phase for several more 
hours compared to the cell expressing WT TLK1B. Our 
explanation for these results is that premature phos-
phorylation of Rad9 mediated by the inactivation resist-
ant TLK1B mutant leads to the dissociation of the 9-1-1 
complex from sites of damage and stalled forks (Fig. 10). 
This dissociation leads to fork collapse and generation of 
DSBs marked by increase in γH2AX and activated ATM. 
ATM activates Chk1, marked by its phosphorylation 
at S317 and S345, which mediates cell cycle arrest. The 
premature dissociation of the 9-1-1 complex from stalled 
forks in Mut TLK1B expressing cells results in lesser 
amount of Rad9 associated with Hus1 and WRN. In fact, 
there was less WRN in association with chromatin after 
release from HU in Mut TLK1B expressing cells, which 
would be expected to result in increased fork collapse, 
as WRN promotes replication fork recovery [62]. Thus, 
in this study we have identified the significance of Rad9 
S328 phosphorylation and have shown that the presence 
of the damage resistant active TLK1B targets Rad9 to the 
cytoplasm. We should emphasize that loss of Rad9 from 
the nucleus can increase the instances of chromosomal 
breakage leading to genomic instability. Scott Davey’s 
group reported that TLK1 phosphorylates primarily 
Rad9(T335) and that plays a key role in cell cycle progres-
sion and G2/M checkpoint exit [30]. In our Mut TLK1B 
overexpressing cells, the phosphorylation of Rad9 (T355) 
was very weak, but more importantly, we could not see 
a difference in cytoplasmic/nuclear redistribution when 
a T355D mutant was used. The accumulation of Rad9 in 
the cytoplasm is consistent only with the S328 phospho-
rylation data and the S328D substitution, whereas the 
T335D phosphomimetic mutation was not sufficient to 
accumulate Rad9 in the cytoplasm.
Fig. 8 Cell cycle distribution of the cells overexpressing. a Wt TLK1B 
and b Mut TLK1B during a time course after release from HU
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Conclusions
Our collective work has demonstrated that TLK1B acts 
as a chaperone for Rad9. In the absence of TLK1 kinase 
activity, i.e., in presence of DNA damage or when a 
kinase-dead protein is used, we showed that TLK1B pro-
moted the association of Rad9 with a DSB and presum-
ably also SSB. Once the damage is repaired, the kinase 
activity recovers and then TLK1B phosphorylates Rad9 
at S328, promoting its dissociation from 9-1-1 and export 
to the cytoplasm, thereby mediating the deactivation of 
the DDR. In conclusion transient inhibition of the kinase 
after DNA damage is crucial in retaining 9-1-1 at damage 
sites until repair is complete, and mutations in the TLK1 
gene which can activate the kinase may potentially cause 
accumulation of DSBs.
Methods
Hydroxyurea (Catalog No. H8627), doxorubicin hydro-
chloride (Catalog No. D1515), thioridazine hydrochloride 
(Catalog No. T9025), KU-55933 (Catalog No SML1109) 
and G418 disulfate salt (Catalog No. A1720) were pur-
chased from Sigma. Dulbecco’s modified Eagle’s medium 
(DMEM) was obtained from Life Technologies (Catalog 
No. 12100-046), fetal bovine serum (FBS) was obtained 
from Atlanta Biologicals (Catalog No. 900108). Enhanced 
chemiluminescence solution was obtained from Thermo-
Scientific (Catalog number No. 32106).
Antibodies used in this study were: rabbit α-Actin 
(Ab1801, Abcam), rabbit α-Rad9 phospho-328 (AP3225a, 
Abgent), rabbit α-Chk1 phospho-317 (AP3070a, Abgent), 
rabbit α-Chk1 phospho-345 (sc-17922, Santa Cruz 
Biotechnology), goat α-Rad9 (sc-10465, Santa Cruz 
Fig. 9 Chk1 activation in Wt and Mut TLK1B expressing cells after treatment and recovery from HU a Mut TLK1B expressing cells show reduced 
phosphorylation of RPA at T21. During recovery from HU, phosphorylation of Chk1 at S317 and S345 persists for 8 h in cells expressing Mut TLK1B, in 
contrast to Wt expressing cells. b Treatment of cells with KU-55933 leads to a reduction of Chk1 phosphorylation in the Mut TLK1B expressing cells
Page 13 of 16Awate and De Benedetti  BMC Molecular Biol  (2016) 17:3 
Biotechnology), mouse α-Rad9 (sc-8324, Santa Cruz 
Biotechnology), donkey α-goat IgG-HRP (sc-2020, 
Santa Cruz Biotechnology), rabbit α-TLK1 phospho-695 
(4121S, Cell Signaling), α-rabbit IgG-HRP (7074S, Cell 
Signaling), α-mouse IgG-HRP (7076, Cell Signaling), rab-
bit α-TLK1 (GTX102891, GeneTex), mouse α- H2A.X 
phospho-139 (05-636, Millipore), mouse α-Flag (F1804, 
Sigma) and Rabbit α-Flag (F7425, Sigma).
Cell culture
HEK293 cells, obtained from ATCC repository, were 
maintained in DMEM supplemented with 10  % FBS 
and 1  % penicillin–streptomycin at 37  °C in a humidi-
fied incubator with 5 % CO2. For ATM inhibitor experi-
ment, cells were pretreated with 10  µM KU-55933 for 
2 h. 2 mM HU was then added into the media for 16 h. 
For inhibition of TLK cells were pretreated with 10 µM 
Thioridazine hydrochloride (THD) for 2  h before addi-
tion of 2 mM HU.
Cell cycle analysis
HEK293 cells were seeded in T-25 flasks at a density of 
2  ×  105 cells/flask. Cells were treated with 2  mM HU 
for 16  h. They were briefly washed with 1× PBS and 
fresh media was added to the cells. Cells were allowed 
to recover for indicated time points. Cells were washed 
with 1× PBS and trypsinized. Cell suspensions were cen-
trifuged at 1000  rpm for 5  min, and pellets were fixed 
with ethanol and stained with 50 μg/ml propidium iodide 
(Sigma, Catalog No. P4170). Percentages of cells within 
each of the cell cycle compartments (G0/G1, S, or G2/M) 
were determined using a FACS Calibur flow cytometer 
(Becton–Dickinson).
Chromatin‑bound fractionation
To isolate chromatin, ~107cells cells were resuspended in 
buffer A (10 mM HEPES, [pH 7.9], 10 mM KCl, 1.5 mM 
MgCl2, 0.34  M sucrose, 10  % glycerol and 1  mM DTT) 
supplemented with halt EDTA free protease and phos-
phatase inhibitors (Life Technologies, Catalog No. 
78441). Triton X-100 (0.1  %) was added, and the cells 
were incubated for 5 min on ice. Cytosolic proteins were 
separated from nuclei by centrifugation (4 min, 1300×g). 
Nuclei were washed once in solution A, and then lysed in 
solution B (3 mM EDTA, 0.2 mM EGTA and 1 mM dithi-
othreitol) supplemented with halt EDTA free protease 
and phosphatase inhibitors for 30  min. Insoluble chro-
matin was then separated from soluble nuclear proteins 
by centrifugation (4 min, 1700×g), washed once in solu-
tion B, and collected by centrifugation (1 min, 10,000×g). 
The final chromatin pellet was resuspended in SDS sam-
ple buffer. Samples were sonicated for 15  s. Aliquots of 
each fraction were separated on sodium dodecyl sulfate–
polyacrylamide (SDS-PAGE) gels and blotted onto poly-
vinylidene difluoride (PVDF) membranes.
Western blot analysis
Cells were lysed in 1X SDS sample buffer. Lysates were 
sonicated for 15  s and heated at 100  °C for 5  min. Pro-
teins were separated on 6–12  % SDS-PAGE gels and 
transferred to PVDF membranes (Millipore). Membranes 
were incubated with PBS containing 0.05  % Tween 20 
and 5  % non-fat dry milk to block non-specific binding 
and were incubated with primary antibodies; membranes 
were then incubated with appropriate secondary anti-
bodies conjugated to horseradish peroxidase. Immuno-
reactive bands were visualized using chemiluminescence 
reagent.
Construction of mammalian expression vectors 
and generation of stable cell lines
We had cDNA of the human TLK1B cloned into the 
BK-shuttle vector [9]. To sub-clone TLK1B into pIRES2 
vector the TLK1B ORF was amplified by PCR with the 
primers: 5′-GTACCGGAATTCAAAATTATTCAGACT 
GATCTC-3′; 5′-TAATTAGGATCCTGGAGGAAA 
GTCAGTAAGTAATTA-3′, containing an EcoRI and a 
BamHI tail respectively. The TLK1B PCR product was 
sub-cloned in the plasmid pIRES2-EGFP, which was 
cut with the same enzymes. TLK1B S457A mutant was 
generated from pIRES2-EGFP using the QuikChange 
Site-Directed Mutagenesis Kit (Stratagene, Catalog No. 
200518) with the following primer: 5′-GAGAAGAT-
CAAATGCTTCAGGAAACCTACAC-3′.
The PCR product was transformed in bacteria, and the 
presence of the nucleotide substitution was confirmed by 
DNA sequencing. To generate stable cell lines, HEK293 
Fig. 10 Model for the TLK1B mediated phosphorylation of Rad9 
leading to dissociation of 9-1-1 from damage sites and redistribution 
of Rad9 to the cytoplasm
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cells were transfected using Lipofectamine 3000 (Life 
Technologies, L3000001) as per the manufacturer’s pro-
tocol, and stably transfected cells were selected with 
G418 (500 μg/ml). The pIRES2-EGFP permits the trans-
lation of both the TLK1B gene cloned into the multiple 
cloning site and EGFP from the single bicistronic mRNA. 
After 30 days of selection in G418, cells expressing high 
levels of GFP were sorted by flow-cytometry.
We had cDNA of the human Flag-tagged Rad9 cloned 
into an episomal pREP10 vector. Stable expression of 
this vector requires expression of full length EBNA-1. 
To generate stable cell lines we transfected HEK293 c-18 
cells (ATCC CRL-10852) which stably express full length 
EBNA-1. Under G418 selection HEK293 c-18 cells stably 
express EBNA-1 which is required to maintain pREP10 
vector episomally. Maintenance of pREP10 vector 
requires hygromycin selection.
Rad9 S328D and T355D mutant was generated 
using the QuikChange Site-Directed Mutagenesis 
Kit (Stratagene, Catalog No. 200518) with the follow-
ing primers: 5′-CTGCCCTCCATTTCCCTTGAC 
CCTGGCCCCCAG-3′ (Rad9 S328D)5′- CAGTACAGT 
GCCTGGGGATCCCCCACCCAAGAAGTTC-3′ (Rad9 
T355D).
The PCR product was transformed in bacteria, and 
the presence of the nucleotide substitutions were con-
firmed by DNA sequencing. To generate stable cell lines, 
HEK293 c-18 cells were transfected using Lipofectamine 
3000 as per the manufacturer’s protocol, and cells were 
selected under G418 (250 μg/ml) and hygromycin (50 μg/
ml) challenge for 30 days.
Immunofluorescence
Cells were grown on culture slides. To remove solu-
ble proteins and fix chromatin-bound proteins, cells 
were pre-extracted in buffer1 (1 % Triton X-100, 10 mM 
HEPES pH 7.4, 10 mM NaCl and 3 mM MgCl2) supple-
mented with halt EDTA free protease and phosphatase 
inhibitors for 5 min at 4 °C. Cells were then fixed in 4 % 
paraformaldehyde for 10  min at 4  °C and then treated 
in buffer 2 (0.5 % Triton X-100, 20 mM HEPES pH 7.4, 
50 mM NaCl, 3 mM MgCl2 and 300 mM sucrose) supple-
mented with halt EDTA free protease and phosphatase 
inhibitors for 5 min at 4 °C. Cells were then blocked for 
1 h in SuperBlock solution.
To look at Rad9 cellular localization cells were fixed 
with methanol and then rehydrated with PBS and 
blocked for 1  h in SuperBlock solution. Staining with 
primary antibody was performed overnight at 4  °C in 
blocking solution, whereas species specific fluorescein/
Texas red conjugated secondary antibody (Vector Labs) 
was applied for 1  h at RT, followed by counterstaining 
with DAPI. All the primary antibodies were used at a 
1:250 dilution, whereas the secondary antibodies were 
employed at a 1:500 dilution. Fluorescence images were 
captured using a Zeiss Axioskop 2 microscope.
Immunoprecipitation
For co-immunoprecipitation (CoIP) experiment, cells 
were lysed in the lysis buffer (1 % Triton X-100, 0.5 % 
Na-Doxycholate, 150 mM NaCl, 2.5 mM MgCl2, 1 mM 
EGTA, 1  mM EDTA, 20  mM Tris/HCl pH 8.0) sup-
plemented with halt EDTA free protease and phos-
phatase inhibitors. Cell lysates were sonicated for 20 
cycles using Diagenode Bioruptor and then incubated 
with 250 U of benzonase. In total 1.5 mg of cell lysate 
was precleared with protein A/G Sepharose beads and 
then incubated overnight at 4 °C with rabbit polyclonal 
anti-Rad9 (4  μg; Santa Cruz Biotech) or anti-Rabbit 
IgG, and tumbled with 70 μl of protein A/G Sepharose 
beads for 4 h at 4  °C. After extensive washing in CoIP 
buffer, proteins were eluted by boiling treatment in 2X 
electrophoresis sample buffer prior to Western blotting 
analysis.
Comet assay
Neutral comet assay was performed using comet assay 
kit from TREVIGEN (Catalog# 4250-050-K) follow-
ing manufacturer’s instructions. DNA was stained with 
SYBR Gold and fluorescence images were captured using 
a Zeiss Axioskop 2 microscope. Tail moments were quan-
tified for each cell using ImageJ OpenComet plugin. 50 
comet images were measured for each treatment.
Statistics
Statistical analysis of data was done using one way 
analysis of variance (ANOVA) with Sigma Stat statisti-
cal software. A p value of 0.05 or less was considered 
significant.
Additional files
Additional file 1: Figure S1. Immunofluorescence was performed as 
described in methods using the α-Rad9 Ab to detect the cellular distribu-
tion of Rad9 in the overexpressed Wt and mut TLK1B expressing cells.
Additional file 2: Figure S2. A) Distribution of p-Rad9 (T355) in the 
cytoplasmic fraction in Wt and Mut TLK1B expressing cells. Note that 
p-Rad9 (T355) shows an increased cytoplasmic accumulation in Mut 
TLK1B expressing cells after treatment with HU. It should be noted that 
Immobilon Western HRP Substrate (Millipore catalog# WBKLS0500) was 
used which provides high sensitivity. B) Chromatin fractionation assay 
was performed to examine the cellular distribution of the overexpressed 
flag tagged Rad9 (T355D) mutant after treatment with 2 mM HU for 16 h 
and allowing them to recover at indicated timepoints. α-Flag Ab detects 
specifically the cellular distribution of overexpressed flag tagged Rad9 
(T355D) mutant.
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